Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma
Joint Authors
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-04-16
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Objective.
Macrophages are the dominant leukocytes in the tumor microenvironment.
Accumulating evidence revealed that CD204-positive (CD204+) tumor-associated macrophages (TAMs) are associated with the aggressive behavior of various cancers; however, the clinical, pathological, and prognostic associations of CD204+ TAMs with the subtype of lung adenocarcinoma have not been reported.
Methods.
Tissue microarray and immunohistochemistry were constructed from clinical stage I lung adenocarcinomas with radical surgical resection.
The intratumoral density of CD204+ cells was calculated using image analysis software for analyses.
Survival analyses were performed using the Kaplan-Meier method and multivariate Cox proportional hazards regression models.
Results.
The intratumoral density of CD204 was correlated with T stage, nodal involvement, lymphovascular invasion, and cancer relapse after the surgery, but not with age, gender, or smoking history.
The density of CD204 in non-LPD was significantly higher than that in LPD.
The 5-year disease-free survival (DFS) rate of CD204 high-density group was significantly worse than that of CD204 low-density group.
Conclusions.
The expression of CD204 in TAMs is associated with the aggressiveness of lung adenocarcinoma.
Our results suggest that a specific immune microenvironment may be associated with the biological behavior of lung adenocarcinoma.
American Psychological Association (APA)
Sun, Yanbin& Xu, Shun. 2018. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma. BioMed Research International،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1129156
Modern Language Association (MLA)
Sun, Yanbin& Xu, Shun. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma. BioMed Research International No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1129156
American Medical Association (AMA)
Sun, Yanbin& Xu, Shun. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1129156
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1129156